NW3-17449-84211
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 112 / NY
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
- 2021-03-22
-
2021-04-05
Dose 2 — Pfizer-BioNTech
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: GoodFree text: COVID-19 positive testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-28
- 2021-05-05
- 2021-05-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): COVID-19 positive test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release